EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endothelial YAP/TAZ activation promotes atherosclerosis in a mouse model of Hutchinson-Gilford progeria syndrome

Ana Barettino, Cristina González-Gómez, Pilar Gonzalo, María J Andrés-Manzano, Carlos R Guerrero, Francisco M Espinosa, Rosa M Carmona, Yaazan Blanco, Beatriz Dorado, Carlos Torroja, Fátima Sánchez-Cabo, Ana Quintas und 5 weitere

Journal of Clinical Investigation · 15.11.2024 · 134 (22)

DOI: 10.1172/jci173448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.10.2024. Verfasst von Ana Barettino und 16 weiteren Autor:innen. Beteiligte Einrichtung: Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain. Hauptthemen laut MEDLINE: Progeria, YAP-Signaling Proteins, Atherosclerosis, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación (MCIN) and Agencia Estatal de Investigación (AEI), Comunidad de Madrid, NA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hutchinson-Gilford progeria syndrome (HGPS) is an extremely rare disease caused by the expression of progerin, an aberrant protein produced by a point mutation in the LMNA gene. HGPS patients show accelerated aging and die prematurely mainly from complications of atherosclerosis such as myocardial infarction, heart failure, or stroke. However, the mechanisms underlying HGPS vascular pathology remain ill-defined. We used single-cell RNA sequencing to characterize the aorta in progerin-expressing Lmna G609G/G609G mice and wild-type controls, with a special focus on endothelial cells (ECs). HGPS ECs showed gene expression changes associated with extracellular matrix alterations, increased leukocyte extravasation, and activation of the yes-associated protein 1/transcriptional activator with PDZ-binding domain (YAP/TAZ) mechanosensing pathway, all validated by different techniques. Atomic force microscopy experiments demonstrated stiffer subendothelial extracellular matrix in progeroid aortae, and ultrasound assessment of live HGPS mice revealed disturbed aortic blood flow, both key inducers of the YAP/TAZ pathway in ECs. YAP/TAZ inhibition with verteporfin reduced leukocyte accumulation in the aortic intimal layer and decreased atherosclerosis burden in progeroid mice. Our findings identify endothelial YAP/TAZ signaling as a key mechanism of HGPS vascular disease and open a new avenue for the development of YAP/TAZ-targeting drugs to ameliorate progerin-induced atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProgeriaYAP-Signaling ProteinsAtherosclerosisAdaptor Proteins, Signal TransducingDisease Models, AnimalEndothelial CellsAnimalsMiceHumansAortaLamin Type AMice, TransgenicTranscriptional Coactivator with PDZ-Binding Motif ProteinsTrans-ActivatorsCell Cycle Proteins

Stichwörter der Autor:innen

AgingAtherosclerosisCardiovascular diseaseEndothelial cellsVascular biology

Substanzen

YAP-Signaling ProteinsYap1 protein, mouseAdaptor Proteins, Signal TransducingWwtr1 protein, mouseLamin Type ATranscriptional Coactivator with PDZ-Binding Motif ProteinsTrans-ActivatorsCell Cycle ProteinsLmna protein, mouse

Autor:innen und Institutionen

  • Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
  • CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
  • Instituto de Ciencia de Materiales de Madrid (ICMM) and.
  • Centro de Investigaciones Biológicas Margarita Salas (CIB), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.

Förderung

  • Ministerio de Ciencia e Innovación (MCIN) and Agencia Estatal de Investigación (AEI)
  • Comunidad de Madrid
  • NA

Zitieren

APA

Barettino, A., González-Gómez, C., Gonzalo, P., Andrés-Manzano, M. J., Guerrero, C. R., Espinosa, F. M., Carmona, R. M., Blanco, Y., Dorado, B., Torroja, C., Sánchez-Cabo, F., Quintas, A., Benguría, A., Dopazo, A., García, R., Benedicto, I., & Andrés, V. (2024). Endothelial YAP/TAZ activation promotes atherosclerosis in a mouse model of Hutchinson-Gilford progeria syndrome. Journal of Clinical Investigation, 134(22). https://doi.org/10.1172/jci173448

Vancouver

Barettino A, González-Gómez C, Gonzalo P, Andrés-Manzano MJ, Guerrero CR, Espinosa FM, et al. Endothelial YAP/TAZ activation promotes atherosclerosis in a mouse model of Hutchinson-Gilford progeria syndrome. Journal of Clinical Investigation. 2024;134(22). doi:10.1172/jci173448

BibTeX
@article{Barettino2024,
  author = {Barettino, Ana and González-Gómez, Cristina and Gonzalo, Pilar and Andrés-Manzano, María J and Guerrero, Carlos R and Espinosa, Francisco M and Carmona, Rosa M and Blanco, Yaazan and Dorado, Beatriz and Torroja, Carlos and Sánchez-Cabo, Fátima and Quintas, Ana and Benguría, Alberto and Dopazo, Ana and García, Ricardo and Benedicto, Ignacio and Andrés, Vicente},
  title = {Endothelial YAP/TAZ activation promotes atherosclerosis in a mouse model of Hutchinson-Gilford progeria syndrome},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  volume = {134},
  number = {22},
  doi = {10.1172/jci173448}
}
Kostenlos starten →